EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy
2013 · British Journal of Cancer · 66 citations
https://doi.org/10.1038/bjc.2013.577
T
Takumi Kumai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
161
Papers
1.9K
Citations
24
h-index
43
i10-index
Takumi Kumai is an academic researcher. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & CAR-T cell therapy research. The author has an h-index of 24, co-authored 137 publications.
ORCID: 0000-0002-3411-671XPapers by this author
worksSix-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer
2011 · Journal of Translational Medicine · 32 citations
https://doi.org/10.1186/1479-5876-9-191
PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma
2019 · Journal of Translational Medicine · 17 citations
https://doi.org/10.1186/s12967-019-1957-5
IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancer
2022 · Translational Oncology · 9 citations
https://doi.org/10.1016/j.tranon.2022.101358
Treatment outcomes of alternating chemoradiotherapy for nasopharyngeal carcinoma: a single-center safety and efficacy study
2022 · Brazilian Journal of Otorhinolaryngology · 2 citations
https://doi.org/10.1016/j.bjorl.2022.12.004
An Otogenic Variant of Lemierre's Syndrome Caused by Trueperella bernardiae: A Case Report and Literature Review
2023 · Cureus · 2 citations
https://doi.org/10.7759/cureus.42977
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat